Home › NDC Lookup › RxCUI directory › RxCUI 546624

Voriconazole 40 MG/ML Oral Suspension [Vfend] — RxCUI 546624

Name: Voriconazole 40 MG/ML Oral Suspension [Vfend] (RxCUI 546624)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 546624 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI546624

Official nameVoriconazole 40 MG/ML Oral Suspension [Vfend]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVfend 40 MG/ML Oral Suspension; Vfend 40 MG in 1 mL Oral Suspension; Vfend 200 MG per 5 ML Oral Suspension; Vfend 40 MG per 1 ML Oral Suspension

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)111 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Voriconazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats serious fungal infections. These include invasive aspergillosis, Candida infections in the blood or deep tissues, esophageal candidiasis, and certain Scedosporium and Fus...
It is usually dosed every 12 hours as a tablet, oral suspension or IV infusion. High-fat meals can lower how much medicine you absorb, so ask me about timing with food. Follow your...
Vision changes, fever, nausea, vomiting, rash, headache, chills, fast heartbeat and abnormal liver tests are common. Some people have hallucinations. Tell your doctor about anythin...
Call for yellow skin or eyes, a fast or irregular heartbeat, fainting, a severe blistering or peeling rash, or vision problems that last. Also call for chest tightness or trouble b...

📖 Read our full Voriconazole guide →

🕸️ Concept Web — How Voriconazole 40 MG/ML Oral Suspension [Vfend] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Voriconazole 40 MG/ML Oral Suspension [Vfend] RxCUI 546624 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Voriconazole 121243 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vfend 338272 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Voriconazole Oral Suspension 477141 SCDF
- Voriconazole Oral Liquid Product 1164591 SCDG
- Voriconazole Oral Product 1164592 SCDG
- Voriconazole Oral Suspension [Vfend] 546623 SBDF
- Vfend Oral Liquid Product 1188085 SBDG
- Vfend Oral Product 1188086 SBDG
- Oral Suspension 316969 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Voriconazole 40 MG/ML Oral Suspension 465355 SCD
- Voriconazole 40 MG/ML 477139 SCDC
- Voriconazole 40 MG/ML [Vfend] 546622 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Voriconazole 40 MG/ML Oral Suspension SCD · 465355
Voriconazole 40 MG/ML SCDC · 477139
Voriconazole Oral Suspension SCDF · 477141
Voriconazole Oral Liquid Product SCDG · 1164591
Voriconazole Oral Product SCDG · 1164592

Brand-Name Concepts

Voriconazole 40 MG/ML [Vfend] SBDC · 546622
Voriconazole Oral Suspension [Vfend] SBDF · 546623
Vfend Oral Liquid Product SBDG · 1188085
Vfend Oral Product SBDG · 1188086
Vfend BN · 338272

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 546624 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00049-3160-44	1 BOTTLE in 1 CARTON (0049-3160-44) / 75 mL in 1 BOTTLE	VFEND	Roerig	2003-03-28
00049-3180-30	30 TABLET, FILM COATED in 1 BOTTLE (0049-3180-30)	VFEND	Roerig	2003-03-28
00049-3190-28	1 VIAL, SINGLE-DOSE in 1 CARTON (0049-3190-28) / 20 mL in 1...	VFEND	Roerig	2003-03-28

Observed labelers: Roerig (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3465	Injection, voriconazole	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.